Cleared Traditional

K201816 - ARTHROTAP

K201816 is an FDA 510(k) clearance for ARTHROTAP, manufactured by Accuro Technologies, Inc.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 107-day FDA review.

K201816 · Accuro Technologies, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2020
Decision
107d
Days
Class 2
Risk

K201816 is an FDA 510(k) clearance for the ARTHROTAP. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Accuro Technologies, Inc. (Victoria, CA). The FDA issued a Cleared decision on October 16, 2020 after a review of 107 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Accuro Technologies, Inc. devices

FDA 510(k) Submission Details - K201816

510(k) Number K201816 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2020
Decision Date October 16, 2020
Days to Decision 107 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 129d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 480
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K201816.
Insulin Syringe
K193273 · Promisemed Hangzhou Meditech Co., Ltd. · Jan 2021
S dispensing line
K192770 · Aea Srl · Dec 2020
Sterile Hypodermic Syringe for Single Use, with/without needle, luer/luer-lock, Sterile Insulin Syringe for Single Use, with needle, Sterile Hypodermic needle for Single use
K201284 · Set Medikal Sanayi VE Ticaret Anonim Sirketi · Dec 2020
3D GraftRasp System
K201900 · Surgentec · Sep 2020
Syringe with safety needle, Safety needle
K193526 · Jiangsu Caina Medical Co.,Ltd · Jul 2020
BD SoloShot Mini Syringe/ BD Auto Disable Syringe
K201234 · Becton, Dickinson and Company · Jul 2020